ArticleAmerican journal of obstetrics and gynecology2014
What is the optimal gestational age for women with gestational diabetes type A1 to deliver?
Article in American journal of obstetrics and gynecology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Diabetes mellitus: an independent predictor of duration of prostaglandin labor induction.Journal of perinatology : official journal of the California Perinatal Association · 2017Trial
- Outcomes after 39 weeks among pregnant patients with diet-controlled gestational diabetes mellitus.Pregnancy (Hoboken, N.J.) · 2026Article
- Gestational diabetes mellitus: The optimal time of delivery.World journal of diabetes · 2023Review
- Optimal delivery time for patients with diet-controlled gestational diabetes mellitus: a single-center real-world study.BMC pregnancy and childbirth · 2022Article
- Gestational Diabetes - Major New Clinically Relevant Aspects.Geburtshilfe und Frauenheilkunde · 2018Article
- Optimal Obstetric Management for Women with Diabetes: the Benefits and Costs of Fetal Surveillance.Current diabetes reports · 2018Review
- Timing of delivery and pregnancy outcomes in women with gestational diabetes.American journal of obstetrics and gynecology · 2016Article
- Global architecture of gestational diabetes research: density-equalizing mapping studies and gender analysis.Nutrition journal · 2016Review
- Hyperglycemia down-regulates cGMP-dependent protein kinase I expression in first trimester cytotrophoblast cells.Molecular and cellular biochemistry · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveType A1 gestational diabetes mellitus (A1GDM), also known as diet-controlled gestational diabetes, is associated with an increase in adverse perinatal outcomes such as macrosomia and Erb palsy. However, it remains unclear when to deliver these women because optimal timing of delivery requires balancing neonatal morbidities from early term delivery against the risk of intrauterine fetal demise (IUFD). We sought to determine the optimal gestational age (GA) for women with A1GDM to deliver. STUDY
designA decision-analytic model was built to compare the outcomes of delivery at 37-41 weeks in a theoretical cohort of 100,000 women with A1GDM. Strategies involving expectant management until a later GA accounted for probabilities of spontaneous delivery, indicated delivery, and IUFD during each week. GA-associated risks of neonatal complications included cerebral palsy, infant death, and Erb palsy. Probabilities were derived from the literature, and total quality-adjusted life years were calculated. Sensitivity analyses were used to investigate the robustness of the baseline assumptions.
resultsOur model showed that induction at 38 weeks maximized quality-adjusted life years. Within our cohort, delivery at 38 weeks would prevent 48 stillbirths but lead to 12 more infant deaths compared to 39 weeks. Sensitivity analysis revealed that 38 weeks remains the optimal timing of delivery until IUFD rates fall <0.3-fold of our baseline assumption, at which point expectant management until 39 weeks is optimal.
conclusionBy weighing the risks of IUFD against infant deaths and neonatal morbidities from early term delivery, we determined that the ideal GA for women with A1GDM to deliver is 38 weeks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.